Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check6 days agoChange DetectedAdded a related topic for Multiple myeloma and MedlinePlus Genetics; updated page revision to v3.4.2. Removed the government funding lapse notice and prior revision v3.4.1.SummaryDifference0.6%

- Check13 days agoChange DetectedAdded a government funding lapse notice and a site revision tag (Revision: v3.4.1). Removed the 'Multiple Myeloma' topic and related MedlinePlus Genetics entry, along with the prior revision tag (v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check20 days agoChange DetectedMinor UI and metadata updates were made on the study page, including a glossary toggle, addition of related topics (Multiple myeloma and MedlinePlus Genetics), and a footer revision from v3.3.4 to v3.4.0 with capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and related entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedRevision: v3.3.4 added; references to 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the related topics area, and 'Revision: v3.3.3' was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the Related Topics section; this is a minor navigational update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedRelated topics links for 'Multiple myeloma' and 'MedlinePlus Genetics' were removed. This reduces navigational links but does not alter the study's details or results.SummaryDifference0.2%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.